Aldevron

Aldevron, established in 1998, is a privately held biotechnology company specializing in the development and manufacturing of critical biological materials. Operating within the Pharmaceuticals and Healthcare sectors, Aldevron focuses on producing high-quality plasmid DNA, proteins, enzymes, and antibodies. The company is strategically located in North Dakota, serving as a key supplier for research and development initiatives across various life science disciplines. Its commitment to quality and precision manufacturing underpins its role in advancing scientific discovery and therapeutic development.

With a workforce ranging from 1,000-5,000 employees, Aldevron operates across 4 locations, demonstrating significant operational scale. The company generates substantial revenue, reported at $211.3M, reflecting its market presence and demand for its specialized products. Aldevron's extensive manufacturing capabilities support complex projects, from early-stage research to clinical applications. To understand the human capital driving these advancements, you can Meet Aldevron's team and learn about the expertise behind their operations.

Aldevron's product portfolio includes custom nucleic acids, recombinant proteins, and antibodies, essential for cell therapy, vaccine development, and molecular diagnostics. The company's services extend to contract manufacturing and development, providing tailored solutions for academic institutions, pharmaceutical companies, and diagnostic developers. Its website, www.aldevron.com, details its comprehensive offerings. Aldevron plays a vital role in the biotechnology supply chain, enabling critical research and the development of life-changing therapies and diagnostics.